Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23
Closed -$7.54K 150
2025
Q4
$7.54K Sell
23
-143
-86% -$45.4K 0.01% 239
2025
Q3
$47K Buy
+166
New +$48.1K 0.04% 172
2025
Q2
Sell
-171
Closed -$53.2K 195
2025
Q1
$53.2K Buy
171
+24
+16% +$7.09K 0.05% 143
2024
Q4
$38.1K Buy
+147
New +$43.6K 0.04% 156

Other funds holding AMGN

Winnow Wealth's AMGN Position: Q1 2026 in Review

Winnow Wealth sold out of Amgen (AMGN) in Q1 2026, closing a stake of 23 shares — an estimated $7.54K sold.

Winnow Wealth first reported a position in AMGN in Q4 2024 and held it in 4 quarters. The position peaked at $53.2K in Q1 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Winnow Wealth reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Winnow Wealth sold 23 Amgen shares in Q1 2026, an estimated $7.54K.
  • Winnow Wealth first reported a position in Amgen in Q4 2024 and held it in 4 quarters.
  • Winnow Wealth's Amgen position peaked at $53.2K in Q1 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Winnow Wealth's 13F filing for Q1 2026, filed 19 May 2026.